Development Of a Concentrated Tranexamic Acid (TXA) Intramuscular Injection

Award NoticeAwarded

Este contrato federal ha sido adjudicado a el September 30, 2025.

Buscar Oportunidades Activas Similares Seguir a HEALTH AND HUMAN SERVICES, DEPARTMENT OF Explorar Contratos NAICS 541714

Información de Adjudicación

HEALTH AND HUMAN SERVICES, DEPARTMENT OF adjudicó este contrato a por $186,004,780 el September 30, 2025, como parte de federal procurement initiatives.

Esta adjudicación es parte de actividades de federal acquisition.

Número de Adjudicación: 75A50125C00018
Monto de Adjudicación: $186,004,780
Fecha de Adjudicación: September 30, 2025

Ver detalles completos en USASpending.gov

Puntos Clave

Competencia abierta completa - todas las empresas pueden participar
Trabajo a realizarse en WASHINGTON, DC
Industria: Research and Development in Biotechnology (except Nanobiotechnology)

Detalles del Contrato

ID de Aviso: 75A50125C00018
Tipo de Oportunidad: Award Notice
Agencia: HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-Agencia: OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Oficina: BARDA - ASPR / DAAPPO / BARDA DCMA
Fecha de Publicación: Wednesday, October 1, 2025
Fecha Límite de Respuesta: No especificado
Código NAICS: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Código PSC: AN13
Reserva: Competencia Abierta Completa
Lugar de Desempeño: WASHINGTON, DC, 20515
Estado: Activo

Ver en SAM.gov

Descripción

This award is for the development of a concentrated Tranexamic Acid (TXA) Intramuscular Injection. The Government seeks this development in order to receive FDA approval for the concentrated IM TXA formulation that can be delivered in a pref-filled syringe or a dedicated autoinjector. This contract action was awarded competitively as a Cost Share Contract. A Cost Share Contract was used in accordance with FAR 35.006 (c) due to an absence of precise specifications and difficulties in estimating costs with accuracy.

Por Qué Importa Esta Oportunidad

HEALTH AND HUMAN SERVICES, DEPARTMENT OF está buscando respuestas para research and development in biotechnology (except nanobiotechnology) en WASHINGTON, DC.

Oportunidades Similares

AJ11-VA Depleted Uranium Program PO 512C50314

VETERANS AFFAIRS, DEPARTMENT OF•MD

Q-RNAscope In-House Assay

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•MD

Low-cost, Connected, Digital Lateral Flow Platform to Detect Influenza A, Influenza B, and SARS-Cov -2 for use in Over-the-Counter (OTC) Settings

HEALTH AND HUMAN SERVICES, DEPARTMENT OF•DC

A-High Throughput Transcriptomics (HTTr)

ENVIRONMENTAL PROTECTION AGENCY•OH

human-derived monoclonal antibodies (mAbs) and viral recombinant antigens (Ags)

DEPT OF DEFENSE•MD

Explorar Relacionados

Más de HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Ver todos los contratos de esta agencia

Contratos en DC

Explorar oportunidades en este estado

Research and Development in Biotechnology (except Nanobiotechnology)

Contratos NAICS 541714

¿Buscas más oportunidades?

Explora nuestro directorio completo de contratos gubernamentales

Ver Todos los Contratos